1. Home
  2. LXRX vs ATNI Comparison

LXRX vs ATNI Comparison

Compare LXRX & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ATNI
  • Stock Information
  • Founded
  • LXRX 1995
  • ATNI 1987
  • Country
  • LXRX United States
  • ATNI United States
  • Employees
  • LXRX N/A
  • ATNI N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ATNI Telecommunications Equipment
  • Sector
  • LXRX Health Care
  • ATNI Telecommunications
  • Exchange
  • LXRX Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • LXRX 273.9M
  • ATNI 240.6M
  • IPO Year
  • LXRX 2000
  • ATNI 1991
  • Fundamental
  • Price
  • LXRX $0.69
  • ATNI $15.32
  • Analyst Decision
  • LXRX Buy
  • ATNI Strong Buy
  • Analyst Count
  • LXRX 2
  • ATNI 2
  • Target Price
  • LXRX $6.00
  • ATNI $31.00
  • AVG Volume (30 Days)
  • LXRX 5.0M
  • ATNI 102.7K
  • Earning Date
  • LXRX 03-10-2025
  • ATNI 02-19-2025
  • Dividend Yield
  • LXRX N/A
  • ATNI 6.27%
  • EPS Growth
  • LXRX N/A
  • ATNI N/A
  • EPS
  • LXRX N/A
  • ATNI N/A
  • Revenue
  • LXRX $5,229,000.00
  • ATNI $747,493,000.00
  • Revenue This Year
  • LXRX $842.94
  • ATNI N/A
  • Revenue Next Year
  • LXRX $19.76
  • ATNI $1.20
  • P/E Ratio
  • LXRX N/A
  • ATNI N/A
  • Revenue Growth
  • LXRX 886.60
  • ATNI N/A
  • 52 Week Low
  • LXRX $0.62
  • ATNI $14.85
  • 52 Week High
  • LXRX $3.73
  • ATNI $38.96
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 40.93
  • ATNI 32.34
  • Support Level
  • LXRX $0.70
  • ATNI $14.90
  • Resistance Level
  • LXRX $0.75
  • ATNI $16.85
  • Average True Range (ATR)
  • LXRX 0.08
  • ATNI 0.77
  • MACD
  • LXRX -0.00
  • ATNI 0.07
  • Stochastic Oscillator
  • LXRX 7.14
  • ATNI 20.26

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise US Telecom and International Telecom. The company earns revenue from its telecommunication services.

Share on Social Networks: